Mechanisms of Lipodystrophy in HIV-Infected Pateints

NCT00457665 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

56

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Nelfinavir
DRUG: Efavirenz

Sponsor

University of Texas Southwestern Medical Center

Collaborators

[object Object]
[object Object]